sulforaphane has been researched along with Experimental Mammary Neoplasms in 8 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sulforaphane (1-5 micromol/L) decreased aldehyde dehydrogenase-positive cell population by 65% to 80% in human breast cancer cells (P < 0." | 7.76 | Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. ( Clouthier, SG; Korkaya, H; Lee, HF; Li, Y; Liu, S; Newman, B; Schwartz, SJ; Sun, D; Wicha, MS; Yu, Y; Zhang, T, 2010) |
| " Results of studies in a rat orthotopic breast cancer model indicated that SFN enhanced the efficacy of DOX in regression of tumor growth, and that the DOX dosage required to treat the tumor could be reduced when SFN was administered concomitantly." | 5.48 | Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model. ( Awasthi, S; Beneš, H; Boerma, M; Bose, C; Hauer-Jensen, M; Sharma, R; Singh, SP, 2018) |
| "Sulforaphane (1-5 micromol/L) decreased aldehyde dehydrogenase-positive cell population by 65% to 80% in human breast cancer cells (P < 0." | 3.76 | Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. ( Clouthier, SG; Korkaya, H; Lee, HF; Li, Y; Liu, S; Newman, B; Schwartz, SJ; Sun, D; Wicha, MS; Yu, Y; Zhang, T, 2010) |
| "Sulforaphane (SFN) is an isothiocyanate derived from broccoli that is currently under evaluation in multiple clinical trials for prevention of several diseases, including cancer." | 1.56 | Sulforaphane Diminishes the Formation of Mammary Tumors in Rats Exposed to 17β-Estradiol. ( Chartoumpekis, DV; Fazzari, M; Kensler, TW; Liao, Y; Michalopoulos, GK; Oesterreich, S; Palliyaguru, DL; Skoko, JJ; Wendell, SG; Yang, L, 2020) |
| "Moreover, in an orthotopic breast cancer model, the nanoparticles achieved a significantly higher tumor accumulation and exhibited a more powerful antitumor activity." | 1.51 | Sulforaphane Mediates Glutathione Depletion via Polymeric Nanoparticles to Restore Cisplatin Chemosensitivity. ( Bao, Y; Han, X; Li, Y; Min, H; Nie, G; Qi, S; Qi, Y; Shi, J; Xu, Y; Zhang, Y; Zhao, X, 2019) |
| " Results of studies in a rat orthotopic breast cancer model indicated that SFN enhanced the efficacy of DOX in regression of tumor growth, and that the DOX dosage required to treat the tumor could be reduced when SFN was administered concomitantly." | 1.48 | Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model. ( Awasthi, S; Beneš, H; Boerma, M; Bose, C; Hauer-Jensen, M; Sharma, R; Singh, SP, 2018) |
| "05) reduced PCNA and elevated PARP fragmentation in samples from animals dosed with SUL." | 1.32 | Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization. ( Jackson, SJ; Singletary, KW, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, DS | 1 |
| Park, EJ | 1 |
| Kang, YH | 1 |
| Hawthorne, ME | 1 |
| Vigo, JS | 1 |
| Graham, JG | 1 |
| Cabieses, F | 1 |
| Fong, HH | 1 |
| Mehta, RG | 2 |
| Pezzuto, JM | 2 |
| Kinghorn, AD | 1 |
| Xu, Y | 1 |
| Han, X | 1 |
| Li, Y | 2 |
| Min, H | 1 |
| Zhao, X | 1 |
| Zhang, Y | 2 |
| Qi, Y | 1 |
| Shi, J | 1 |
| Qi, S | 1 |
| Bao, Y | 1 |
| Nie, G | 1 |
| Palliyaguru, DL | 1 |
| Yang, L | 1 |
| Chartoumpekis, DV | 1 |
| Wendell, SG | 1 |
| Fazzari, M | 1 |
| Skoko, JJ | 1 |
| Liao, Y | 1 |
| Oesterreich, S | 1 |
| Michalopoulos, GK | 1 |
| Kensler, TW | 2 |
| Bose, C | 1 |
| Awasthi, S | 1 |
| Sharma, R | 1 |
| Beneš, H | 1 |
| Hauer-Jensen, M | 1 |
| Boerma, M | 1 |
| Singh, SP | 1 |
| Zhang, T | 1 |
| Korkaya, H | 1 |
| Liu, S | 1 |
| Lee, HF | 1 |
| Newman, B | 1 |
| Yu, Y | 1 |
| Clouthier, SG | 1 |
| Schwartz, SJ | 1 |
| Wicha, MS | 1 |
| Sun, D | 1 |
| Jackson, SJ | 1 |
| Singletary, KW | 1 |
| Cho, CG | 1 |
| Posner, GH | 1 |
| Talalay, P | 1 |
| Gerhäuser, C | 1 |
| You, M | 1 |
| Liu, J | 1 |
| Moriarty, RM | 1 |
| Hawthorne, M | 1 |
| Moon, RC | 1 |
8 other studies available for sulforaphane and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Potential cncer chemopreventive flavonoids from the stems of Tephrosia toxicaria.
Topics: Animals; Anticarcinogenic Agents; Carcinoma, Hepatocellular; Chromones; Flavonoids; Heterocyclic Com | 2003 |
Sulforaphane Mediates Glutathione Depletion via Polymeric Nanoparticles to Restore Cisplatin Chemosensitivity.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Cell Survival; Cisp | 2019 |
Sulforaphane Diminishes the Formation of Mammary Tumors in Rats Exposed to 17β-Estradiol.
Topics: Animals; Anticarcinogenic Agents; Cell Proliferation; DNA Damage; Estradiol; Fatty Acids; Female; Is | 2020 |
Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; | 2018 |
Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells.
Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase 1 Family; Animals; Anticarcinogenic Agents; Apoptosis | 2010 |
Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Caspases; CDC2 Protein Kinase; Cell Division; Chromatin | 2004 |
Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Female; Isothiocyanates; Mammary N | 1994 |
Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes.
Topics: Animals; Anticarcinogenic Agents; Chloramphenicol O-Acetyltransferase; Enzyme Induction; Female; Gen | 1997 |